Prophylactic vs. Intermediate Tinzaparin Dosage for the Thromboprophylaxis of Acutely Ill Medical Patients at High Risk of Venous Thromboembolism
These findings reveal that intermediate tinzaparin dosing is a more effective and safe approach in high-risk for VTE hospitalized patients, emphasizing the need for personalized VTE management.
Authors
- Vasiliki Dimakopoulou (ORCID: https://orcid.org/0000-0003-1811-7621)
- C. Savopoulos (ORCID: https://orcid.org/0009-0003-4181-7439)
- Eleni Karlafti (ORCID: https://orcid.org/0000-0001-7094-0338)
- Georgia Kaiafa (ORCID: https://orcid.org/0000-0001-8000-4500)
- Konstantinos G. Moulakakis (ORCID: https://orcid.org/0000-0002-2269-5937)
- Eleftheria Ztriva (ORCID: https://orcid.org/0000-0002-4013-2767)
- Vasileios Patriarcheas (ORCID: https://orcid.org/0000-0001-6561-321X)
- Angelos Perperis (ORCID: https://orcid.org/0000-0003-2290-3940)
- Stamatia Tsoupra
- Karolina Akinosoglou (ORCID: https://orcid.org/0000-0002-4289-9494)
- Eleni Polyzou
- Ioannis Chandroulis
- Periklis Davlouros
Institutions
- University of Patras (GR)
- Aristotle University of Thessaloniki (GR)
- Hellenic Open University (GR)
- AHEPA University Hospital (GR)
- General University Hospital of Patras (GR)
- University General Hospital Attikon (GR)
Publication Details
- Journal
- Medical Sciences
- Published
- 2025-11-27
- DOI
- https://doi.org/10.3390/medsci13040291
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00